J Studios/DigitalVision via Getty Images Investment Overview Austin, Texas-based Cassava Sciences, Inc. (NASDAQ:SAVA) announced its Q2 2024 earnings today, and in early trading today, shares have dipped in value by ~5%, falling to $29 per share, which translates to a market cap valuation for the company of $1.4bn. I last covered Cassava in early July, discussing the indictment of a key Cassava advisor, Dr. Hoau-Yan Wang, for alleged fraud. In that note, I gave Cassava stock a “hold” rating. However, sha ...